ADURO CLEAN TECHNOLOGIES INC.

Notes:

(1) Assumes a closing of the Public Offering only.

(2) Assumes a closing of the Public Offering and the LIFE Offering in full.

(3) Expenditures related to the construction of the FOAK Plant relate to the development of Aduro's demonstration-scale Hydrochemolytic Technology plant, which represents the next phase in the Company's commercialization strategy. The FOAK Plant is intended to validate the scalability and commercial viability of the HCT platform for processing hard-to-recycle plastics. The FOAK Plant will build on the Company's pilot-scale development. The FOAK Plant is expected to support data generation for future configurable commercial solutions and will serve as a key milestone in Aduro's transition from pilot to commercial operations.

(4) Aduro is actively advancing the HCT platform through a structured R&D program that supports both pilot-scale and demonstration-scale development. These ongoing R&D costs will fund engineering, process optimization, and testing activities related to the Company's plastics and bitumen applications. R&D activities are conducted both in-house at the Company's facilities in London and Sarnia, Ontario and through external partnerships. These efforts focus on generating data to support commercial readiness. The Company's phased approach ensures that the technology evolves into a highly adaptable solution capable of addressing a wide range of feedstocks

(5) Estimated general corporate and administrative expenses are expected to include, without limitation:

• salaries, contractor and personnel costs (including those of the Company's directors and officers);

• professional fees, including legal, accounting and audit;

• insurance, including directors' and officers' insurance;

• office, facility and general operating costs;

• regulatory, listing and filing fees;

• investor relations activities and communications; and

• travel, conferences and related business development expenses.

The allocation above reflects the Company's current development priorities. Under the minimum offering scenario, the Company expects to prioritize continued pilot plant operations, process optimization and critical path workstreams for demonstration-scale development. Under the maximum offering scenario, additional funds are expected to accelerate engineering and development activities associated with the demonstration-scale plant.

The above allocation represents the Company's current intentions based on its present plans and business conditions and may be reallocated for sound business reasons. See "Cautionary Statement Regarding Forward-Looking Information".

The Company is an early-stage technology company that has not yet generated positive cash flows from operations. The Offering is intended to support ongoing development and commercialization activities.